New Study Reveals Risks of Common Sepsis Treatment
Examining the Impact of Anti-Anaerobic Antibiotics on Sepsis Outcomes
Topline:
A recent study highlights the potential dangers associated with using piperacillin-tazobactam in treating sepsis, revealing increased mortality and prolonged organ dysfunction compared to cefepime.
Keep reading with a 7-day free trial
Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.